A Phase 1b, Open-Label, Multiple Ascending Dose, Multicenter Study of VRG50635 in Participants With Sporadic and Familial Amyotrophic Lateral Sclerosis Followed by Long-Term Treatment

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506509-21-00

Acronym

VGCS-50635-002

Enrollment

Registered

2024-01-22

Start date

2024-03-08

Completion date

2025-08-04

Last updated

2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Finland, Netherlands, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026